UniSa - IRIS Institutional Research Information System

ALTIERI, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.278
EU - Europa 1.551
AS - Asia 976
SA - Sud America 77
Continente sconosciuto - Info sul continente non disponibili 10
AF - Africa 9
OC - Oceania 2
Totale 6.903
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.171
CN - Cina 456
UA - Ucraina 398
DE - Germania 385
RU - Federazione Russa 329
SG - Singapore 266
IT - Italia 176
CA - Canada 102
IE - Irlanda 96
KR - Corea 93
FI - Finlandia 89
VN - Vietnam 77
BR - Brasile 72
HK - Hong Kong 31
IN - India 21
SE - Svezia 21
NL - Olanda 13
TR - Turchia 13
EU - Europa 10
GB - Regno Unito 9
PL - Polonia 6
ES - Italia 5
JP - Giappone 5
CO - Colombia 4
FR - Francia 4
GR - Grecia 4
AT - Austria 3
BD - Bangladesh 3
BE - Belgio 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
KE - Kenya 2
MX - Messico 2
PK - Pakistan 2
RO - Romania 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BZ - Belize 1
CH - Svizzera 1
DZ - Algeria 1
EG - Egitto 1
GH - Ghana 1
HU - Ungheria 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
LK - Sri Lanka 1
MT - Malta 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 6.903
Salva come PNG Salva come JPEG
Città #
Ann Arbor 817
Jacksonville 476
Chandler 406
Princeton 333
Singapore 105
Wilmington 101
Dublin 96
Ottawa 92
Andover 90
Nanjing 86
Nürnberg 86
Ashburn 83
Boardman 76
Dong Ket 76
Woodbridge 76
Beijing 57
Pellezzano 54
Fairfield 39
Houston 39
Jinan 36
Changsha 35
Shenyang 35
Munich 34
Hong Kong 28
Hebei 24
Jiaxing 24
Tianjin 24
Nanchang 20
Naples 20
Pune 17
Zhengzhou 17
Norwalk 15
Seattle 15
Salerno 14
Moscow 13
Redwood City 13
Izmir 11
San Francisco 11
Brooklyn 10
Guangzhou 10
São Paulo 10
Columbus 9
Dallas 9
Hangzhou 9
San Diego 9
Vietri Sul Mare 9
Cambridge 8
Düsseldorf 8
Los Angeles 8
New York 7
Ningbo 7
Nuremberg 7
Turku 7
Boston 6
Mountain View 6
Taiyuan 6
Taizhou 6
Chicago 5
Mestre 5
Rio de Janeiro 5
The Dalles 5
Warsaw 5
Amsterdam 4
Atlanta 4
Edinburgh 4
Fort Worth 4
Guardia Sanframondi 4
Lappeenranta 4
Madrid 4
Montreal 4
Prineville 4
Charlotte 3
Falls Church 3
Fenton 3
Haikou 3
Lanzhou 3
London 3
Marano Di Napoli 3
Phoenix 3
Stockholm 3
Avellino 2
Brussels 2
Casalnuovo di Napoli 2
Castellammare Di Stabia 2
Castellammare di Stabia 2
Central District 2
Chengdu 2
Dearborn 2
Dhaka 2
Dordrecht 2
Englishtown 2
Hefei 2
Horia 2
Indiana 2
Leawood 2
Nairobi 2
Napoli 2
Olomouc 2
Paris 2
Redmond 2
Totale 3.873
Salva come PNG Salva come JPEG
Nome #
Ultrasonographic evaluation of urethrovesical junction mobility: correlation with type of delivery and stress urinary incontinence 329
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 323
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 323
Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol 300
Are Referral Centers for Non-Muscle-Invasive Bladder Cancer Compliant to EAU Guidelines? A Report from the Vesical Antiblastic Therapy Italian Study 101
A randomised study evaluating maintenance schedule in early adjuvant chemotherapy for intermediate risk non-muscle-invasive bladder cancer 99
A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer 96
Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas 92
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers. 90
Concordance and Clinical Significance of Uncommon Variants of Bladder Urothelial Carcinoma in Transurethral Resection and Radical Cystectomy Specimens 88
Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients 87
Altered expression of specific genes in the HOX network is associated with human bladder transitional cell carcinomas 84
Cigarette smoking status at diagnosis and recurrence in intermediate-risk non-muscle-invasive bladder carcinoma 84
PTPD1 Supports Receptor Stability and Mitogenic Signaling in Bladder Cancer Cells 83
A preoperative clinical prognostic model for non-metastatic renal cell carcinoma 83
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms 81
Can pT2 classification for renal cell carcinoma be improved? An international multicenter experience? 81
Prognostic relevance of tumour size in T3a renal cell carcinoma: A multicentre experience 80
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy 79
A nomogram predicting renal cell carcinoma-specific survival in patients with nodal metastases is more accurate than any individual variable 77
Phase II marker lesion study of 6-week intravesical gemcitabine instillation in patients with low risk non muscle invasive bladder tumours 76
Amelanotic Malignant Melanoma of the Male Urethra: A Potential Diagnostic Pitfall 76
Role of Polysomy 17 in Transitional Cell Carcinoma of the Bladder: Immunohistochemical Study of HER2/neu Expression and FISH Analysis of c-erbB-2 Gene and Chromosome 17 74
A randomized trial comparing tamoxifen therapy vs. Tamoxifen prophylaxis in bicalutamide-induced gynecomastia 73
Calcitonin-producing well-differentiated neuroendocrine carcinoma (carcinoid tumor) of the urinary bladder: case report 72
Inhibitory Effect of Standardized Cannabis sativa Extract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility 71
["Classic" vs autolubricant catheterization for endovesicular chemotherapy. Preliminary experience]. 71
Evaluation of expression of chromatin assembly factor-1 (CAF-1) p60 in prostatic preneoplastic lesions 71
Zoledronic Acid Increases the Expression of Ndrg1 Gene In Human Androgen-independent Prostate Cancer Pc3 Cells 70
Significance of tumor size in locally advanced renal cell carcinoma (pT3a): An international multicenter experience 70
Prostate Health Index (phi) Is Able To Discriminate Benign and Precancerous Conditions From Prostate Cancer 69
Cigarette Smoking and Drinking Water Source: Correlation with Clinical Features and Pathology of Superficial Bladder Carcinoma 69
Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: Prognostic indicators of disease-specific survival 69
Prognostic significance of T3A renal cell carcinoma with adrenal gland involvement: An international multicenter experience 69
Contemporary Management of Non-muscle Invasive Bladder Cancer At Italian Referral Centres Adopting Eau Guidelines 68
Docetaxel Retreatment In Docetaxel-pretreated Castration-resistant Prostate Cancer 68
[Erectile dysfunction in kidney transplanted patients]. 68
Modulation of BAG3 expression in human normal urothelial cells by Diuron 68
Can Gemcitabine Instillation Ablate Solitary Low-Risk Non-Muscle-Invasive Bladder Cancer? Results of a Phase II Marker Lesion Study 67
Endovesical Gemcitabine In Recurrent Previously Treated Non-muscle-invasive Bladder Cancer 67
CAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancers 67
[Imaging diagnosis of non-lymph node metastasis of bladder carcinoma]. 67
Frequency, clinical presentation and evolution of renal oncocytomas: Multicentric experience from a European database 67
A serum metabolomic signature for the detection and grading of bladder cancer 67
Gynecomastia due to hormone therapy for advanced prostate cancer: A report of ten surgically treated cases and a review of treatment options 66
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 65
Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer 65
[The Rokitansky-Kuster-Hauser syndrome with chromosome XO/XX mosaicism (single pelvic kidney)]. 65
Radiocontrast media cause dephosphorylation of Akt and downstream signaling targets in human renal proximal tubular cells 64
Matrix Metalloproteinase-2 And-9 In the Urine of Prostate Cancer Patients 63
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy - A multicenter European study 63
Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas 62
Paclitaxel in Pretreated Metastatic Penile Cancer: Final Results of a Phase 2 Study 62
Effects of the Erbb1/erbb2 Kinase Inhibitor Gw2974 On the Growth and Nse, Chromogranin A and Osteopontin Content of the Androgen-independent Prostate Cancer Cell Line Pc-3 61
Pca3 Comparison With Prostate Health Index (phi) In Repeat Biopsy Patients 60
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 59
Distribution of smoking, water resource and other environmental factors in patients affected by superficial bladder cancer 59
Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer 59
Efficacy of one-year maintenance in early adjuvant chemotherapy for intermediate risk non-muscle-invasive bladder cancer. Results at 24 months of a randomized trial 58
Phase II study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer 58
Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading 57
Uracyst Enhances the Antitumor Activity of Drugs In Bladder Cancer Cells 57
Low-dose oral chemotherapy for hormone refractory prostate carcinoma (HRPC). Estramustine phosphate versus estramustine phosphate and etoposide. A randomised phase II study of GSTU Foundation 57
Npc - A Newer Revolutionary Test For Evaluation of Clinical Series. Bladder Cancer 56
Out-patient low-dose oral chemotherapy in hormone refractory prostate carcinoma (HRPC) patients unfit for hospital admittance 55
Oral Chemotherapy in Hormone-Refractory Prostate Carcinoma Patients Unwilling to Be Admitted to Hospital 55
Presence of systemic symptoms is the foremost predictor of mortality in patients with exclusive nodal metastases 55
Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer 55
Effects of the antidepressant St. John's wort (hypericum perforatum) on rat and human vas deferens contractility 55
Drinking water source and cigarette smoking in transitional cell carcinoma of the bladder 54
Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma 54
Proposal for revision of the TNM classification system for renal cell carcinoma 54
Not traditional prognostic factors in human conventional renal carcinoma. 54
Standard versus hydrophilic catheterization in the adjuvant treatment of patients with superficial bladder cancer 53
The best prostate biopsy sampling system—fusion and systematic biopsy: A single center experience 52
Smoking Status, Recurrence Risk and Intravesical Chemotherapy In Non-muscle-invasive Bladder Cancer 52
Docetaxel and Carboplatin In Docetaxel Pretreated Castraction-resistant Prostate Cancer: Preliminary Results 52
Prevalence of silent prostatic adenocarcinoma in 165 patients undergone cystoprostatectomy: A retrospective study 51
Prognostic impact of tumor size on pT2 renal cell carcinoma: An international multicenter experience 50
Effects of the ErbB1/ErbB2 kinase inhibitor GW2974 on androgen-independent prostate cancer PC-3 cell line growth and NSE, chromogranin A and osteopontin content 49
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: A phase II study 49
Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder Cancer: Update 2016 49
Choroidal evaluation in patients under alpha-lytic therapy 49
Predictive accuracy of four prognostic models for non-metastatic renal cell carcinoma after nephrectomy: A comparative study. 48
Preliminary report of a multicentric study on environmental risk factors in Ta-T1 transitional cell carcinoma of the bladder - A study from Gruppo Studi Tumori Urologici (GSTU) Foundation 48
Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: A five year follow-up analysis 46
Urotensin Ii Receptor Is Involved In the Regulation of Motility of Prostate Adenocarcinoma Cells and Predicts the Clinical Outcome of Prostate Cancer Patients 46
Local hyperthermia for treatment of advanced prostatic carcinoma: preliminary results. 45
Role of PA2G4P4 pseudogene in bladder cancer tumorigenesis 45
Ki67 in Gleason Pattern 3 as a Marker of the Presence of Higher-Grade Prostate Cancer 43
KPNA2/ERG Coexpression is Associated with Early Recurrence in Advanced Prostate Cancers 36
Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients? 34
Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the RECORd 2 project) 25
Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project) 17
Totale 6.980
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.917
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021782 152 84 92 10 88 6 83 3 81 8 89 86
2021/2022566 2 0 1 6 7 8 12 30 94 86 68 252
2022/2023975 95 55 16 114 137 231 0 101 139 0 65 22
2023/2024343 44 68 16 20 30 32 8 36 1 3 8 77
2024/2025783 23 6 20 27 16 183 108 90 90 26 81 113
2025/202678 78 0 0 0 0 0 0 0 0 0 0 0
Totale 6.980